Hematologic toxicity of drugs used in cardiovascular disease.
Many diuretic, antiarrhythmic, and antihypertensive drugs have potential hematologic toxicity. Any patient with cardiovascular disease receiving long-term drug therapy or massive doses of a drug should be watched carefully for early detection of hemolysis, thrombocytopenia, neutropenia, or other toxic effects.
D000743:Anemia, Hemolytic / Q000139:chemically induced; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000378:metabolism; D000917:Antibody Formation; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D001769:Blood / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004232:Diuretics / Q000009:adverse effects* / Q000378:metabolism; D004910:Erythrocyte Membrane / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008134:Long-Term Care; D009503:Neutropenia / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001323:Autoantibodies; D004232:Diuretics